These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2568801)

  • 1. Plasma level and renal excretion of iotrolan after lumbar injection in patients.
    Weinmann HJ; Vogelsang H; Mützel W; Speck U
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():224-7. PubMed ID: 2568801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of iotrolan after intravenous injection into healthy volunteers.
    Scholz P; Weinmann HJ; Mützel W; Staks T
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():211-4. PubMed ID: 2568798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue distribution and excretion of iotrolan after intravenous and suboccipital injections in animals.
    Weinmann HJ; Scholz P; Mützel W
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():206-10. PubMed ID: 2568796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative clinical study with iotrolan versus metrizamide in lumbar myelography.
    Inoue S; Watanabe T; Yamamura H
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():161-6. PubMed ID: 2568787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal excretion and computed tomography enhancement of iotrolan and iopamidol in dogs.
    Benness G; Evill C; Wilcox J; Hassam R; Arozoo E
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():88-90. PubMed ID: 2568815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iotrolan versus iopamidol: a controlled, multicenter, double-blind study of lumbar and direct cervical myelography.
    Ringel K; Klotz E; Wenzel-Hora BI
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():153-7. PubMed ID: 2568784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance of iotrolan 190 and cerebrospinal fluid-diluted iotrolan 300 at the same iodine concentration in lumbar myelography.
    Wenzel-Hora BI; Potthoff PC; Jänicke UA
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():148-52. PubMed ID: 2568783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental urography in dogs: diagnostic quality and pharmacokinetic behavior of iotrolan in comparison to nonionic and ionic, monomeric contrast media.
    Nauert C; Mützel W
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():82-7. PubMed ID: 2568814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iotrolan, a nonionic dimeric contrast medium in myelography.
    Bien S; Schumacher M; Berger W; Wenzel-Hora BI
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():158-60. PubMed ID: 2568785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance to iotrolan after subarachnoid injection in animals.
    Press WR; Mützel W; Schöbel C
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():126-33. PubMed ID: 2568780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diskography with iotrolan before chemonucleolysis with chymopapain.
    Bien S; Schumacher M; Ott D
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():143-7. PubMed ID: 2568782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective comparison of iotrolan and iohexol in lumbar myelography.
    Wagner A; Jensen C; Saebye A; Rasmussen TB
    Acta Radiol; 1994 Mar; 35(2):182-5. PubMed ID: 8172748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adverse reactions and intracranial contrast medium after myelography].
    Fujii K; Hashimoto T; Isaza M; Hashimoto T; Hirabuki N; Miura T; Mitomo M; Kozuka T; Kawai R
    Rinsho Hoshasen; 1989 Mar; 34(3):323-7. PubMed ID: 2739082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and excretion of iohexol after lumbar myelography in man.
    Shaw DD; Kido DK; Stroshane RM; Palace GP; Sahler L
    Invest Radiol; 1985 Sep; 20(6):632-7. PubMed ID: 2933362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials with iotrolan in myelographic and computed tomography applications in the United States.
    Goldstein HA; Pfennig D
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():167-70. PubMed ID: 2568788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural tolerance of iotrolan 300 in ascending cervical myelography: results of a multicenter study.
    Behrends B; Albrecht A; Bingas B; Becker H; Brunke J; von Einsiedel H; Mariss G; Schmidt K; Thun F; Valavanis A
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():171-5. PubMed ID: 2568789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution and excretion of 125I ioversol in conscious dogs.
    Coveney JR; Robbins MS
    Invest Radiol; 1989 Jun; 24 Suppl 1():S23-7. PubMed ID: 2592170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The difference of contrast effects of myelography in normal dogs: comparison of iohexol (180 mgI/ml), iohexol (240 mgI/ml) and iotrolan (240 mgI/ml).
    Shimizu J; Yamada K; Kishimoto M; Iwasaki T; Miyake Y
    J Vet Med Sci; 2008 Jul; 70(7):659-63. PubMed ID: 18685236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and pharmacokinetics of iotrolan in hysterosalpingography. Retention and irritability compared with Lipiodol.
    Miyamoto Y; Tsujimoto T; Iwai K; Ishida K; Uchimoto R; Miyazawa T; Azuma H
    Invest Radiol; 1995 Sep; 30(9):538-43. PubMed ID: 8537211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intracranial distribution of iohexol and iotrolan after cervical myelography].
    Fiirgaard B; Madsen HH; Svare U; Skjødt T; Zeeberg I
    Ugeskr Laeger; 1995 Jul; 157(27):3901-4. PubMed ID: 7645065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.